Online Pain Education for Crohn's Disease and Ulcerative Colitis
Not yet recruitingNot applicableNCT07671313
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Through a pilot randomized controlled trial (RCT), we aim to test the feasibility and preliminary impact of two online pain educations programs among adult patients with inflammatory bowel disease (IBD) who experience chronic pain. Each online program can be accessed on the patient's personal device, and will take about 2 hours to complete. Clinical outcomes (pain intensity, pain interference, quality of life) will be assessed via online surveys at baseline and then weekly for 8-weeks post-treatment.
Study details
- Official title
- Randomized Controlled Trial of Online Pain Education Programs for Inflammatory Bowel Disease
- Conditions
- Crohn's Disease
- Ulcerative Colitis (UC)
- Inflammatory Bowel Disease (Crohn's Disease
- Ulcerative Colitis)
- Interventions
- Behavioral: Empowered Relief
- Behavioral: Living Better with Chronic Pain
- Sponsor
- Cedars-Sinai Medical Center
- Start date
- 2026-08
- Primary completion
- 2027-07
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Physician-confirmed diagnosis of Crohn's disease or ulcerative colitis * Chronic pain (visceral and/or somatic) related to IBD for at least 3 months * NIH PROMIS Pain Interference scale T-score ≥60 * Medically stable, defined as: 1. No acute IBD-related hospitalization within the past 3 months; AND 2. No planned IBD surgery or planned therapeutic escalation within the next 2 months, including initiation of a new advanced therapy, dose escalation or switch of advanced therapy, or corticosteroid taper * Able to understand and complete questionnaires independently in English * Access to an internet-enabled device for online surveys and intervention access. Exclusion Criteria: * Cognitive impairment or other condition that, in the opinion of the investigators, would interfere with protocol participation * Current use of standing opioid medications, given the often severe impact of opioids on GI motility and potential for pharmacological visceral hyperalgesia * Prior participation in cognitive behavioral therapy (CBT) specifically targeting chronic IBD-related pain
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07671313